ALYFTREK

VANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTOR · Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for ALYFTREK, covering 2024-12-20 to 2026-08-19. Get the full timeline:

Most recent: EMA Authorised: Alyftrek (deutivacaftor;tezacaftor;vanzacaftor calcium dihydrate) — Vertex Pharmaceuticals (Ireland) Limited